Table 6 Anti-inflammatory activity of crude extracts of selected samples against nitric oxide (NO).
10 | 20 | 40 | 80 | 100 | IC50 (µg g−1) | |
|---|---|---|---|---|---|---|
Inhibition of NO (%) (Mean ± STDEV*) | ||||||
Concentration (µg g−1) | ||||||
ADFL | 20.47 ± 1.67a | 30.51 ± 1.78a | 38.26 ± 2.62a | 68.92 ± 4.16a | 76.11 ± 4.49a | 59.79 |
UFS | 15.00 ± 1.13b | 26.12 ± 1.92b | 28.26 ± 2.01b | 59.21 ± 3.76b | 62.11 ± 3.91b | 72.55 |
SFS | 8.02 ± 0.51d | 13.01 ± 1.01d | 21.00 ± 1.41d | 31.01 ± 2.11d | 39.91 ± 2.11d | – |
GFS | 13.11 ± 1.00c | 20.21 ± 1.88c | 25.11 ± 1.93c | 50.31 ± 3.41c | 56.12 ± 3.16c | 82.77 |
BFS | 6.12 ± 0.42e | 7.51 ± 0.52e | 15.73 ± 1.02e | 26.22 ± 1.96e | 33.11 ± 2.01e | – |